Lucia Lisi - Publications

catholic University Medical School, Washington, DC, United States 
Neuroendocrinology, Neuroimmunology

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lisi L, Pia Ciotti GM, Chiavari M, Pizzoferrato M, Mangiola A, Kalinin S, Feinstein DL, Navarra P. Phospho-mTOR expression in human glioblastoma microglia-macrophage cells. Neurochemistry International. 104485. PMID 31195027 DOI: 10.1016/j.neuint.2019.104485  1
2019 Chiavari M, Ciotti GMP, Navarra P, Lisi L. Pro-Inflammatory Activation of A New Immortalized Human Microglia Cell Line. Brain Sciences. 9. PMID 31096716 DOI: 10.3390/brainsci9050111  1
2018 Kalinin S, González-Prieto M, Scheiblich H, Lisi L, Kusumo H, Heneka MT, Madrigal JLM, Pandey SC, Feinstein DL. Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis. Journal of Neuroinflammation. 15: 141. PMID 29759078 DOI: 10.1186/s12974-018-1184-7  1
2017 Rossetti B, Gagliardini R, Meini G, Sterrantino G, Colangeli V, Re MC, Latini A, Colafigli M, Vignale F, Rusconi S, Micheli V, Di Biagio A, Orofino G, Ghisetti V, Fantauzzi A, ... ... Lisi L, et al. Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial. Plos One. 12: e0187393. PMID 29161288 DOI: 10.1371/journal.pone.0187393  1
2017 Atzori MG, Tentori L, Ruffini F, Ceci C, Lisi L, Bonanno E, Scimeca M, Eskilsson E, Daubon T, Miletic H, Ricci Vitiani L, Pallini R, Navarra P, Bjerkvig R, D'Atri S, et al. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells. Journal of Experimental & Clinical Cancer Research : Cr. 36: 106. PMID 28797294 DOI: 10.1186/s13046-017-0577-2  1
2017 Lisi L, Pizzoferrato M, Miscioscia FT, Topai A, Navarra P. Interactions between Integrase Inhibitors and human Arginase 1. Journal of Neurochemistry. PMID 28397245 DOI: 10.1111/jnc.14039  1
2017 Laudati E, Currò D, Navarra P, Lisi L. Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm. Neurochemistry International. PMID 28279751 DOI: 10.1016/j.neuint.2017.03.002  1
2017 Lisi L, Ciotti GM, Braun D, Kalinin S, Currò D, Dello Russo C, Coli A, Mangiola A, Anile C, Feinstein DL, Navarra P. Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma. Neuroscience Letters. 645: 106-112. PMID 28259657 DOI: 10.1016/j.neulet.2017.02.076  1
2016 Dello Russo C, Lisi L, Tentori L, Navarra P, Graziani G, Combs CK. Exploiting Microglial Functions for the Treatment of Glioblastoma. Current Cancer Drug Targets. PMID 27528361  1
2015 Lisi L, Laudati E, Miscioscia TF, Dello Russo C, Topai A, Navarra P. Antiretrovirals inhibit arginase in human microglia. Journal of Neurochemistry. PMID 26466119 DOI: 10.1111/jnc.13393  1
2015 Pozzoli G, De Simone ML, Cantalupo E, Cenciarelli C, Lisi L, Boninsegna A, Dello Russo C, Sgambato A, Navarra P. The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27(Kip1) protein up-regulation and c-Myc mRNA down-regulation. Molecular and Cellular Endocrinology. 412: 205-15. PMID 25960164 DOI: 10.1016/j.mce.2015.05.004  1
2015 Lisi L, Aceto P, Navarra P, Dello Russo C. mTOR kinase: a possible pharmacological target in the management of chronic pain. Biomed Research International. 2015: 394257. PMID 25685786 DOI: 10.1155/2015/394257  1
2015 Scarsi C, Levesque A, Lisi L, Navarra P. The free fractions of circulating docosahexaenoic acid and eicosapentenoic acid as optimal end-point of measure in bioavailability studies on n-3 fatty acids. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 96: 11-6. PMID 25559240 DOI: 10.1016/j.plefa.2014.12.006  1
2014 Imberti R, De Gregori S, Lisi L, Navarra P. Influence of the oral dissolution time on the absorption rate of locally administered solid formulations for oromucosal use: the flurbiprofen lozenges paradigm. Pharmacology. 94: 143-7. PMID 25277061 DOI: 10.1159/000367663  1
2014 Lisi L, Laudati E, Navarra P, Dello Russo C. The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype. Journal of Neuroinflammation. 11: 125. PMID 25051975 DOI: 10.1186/1742-2094-11-125  1
2014 Romani F, Tropea A, Scarinci E, Federico A, Dello Russo C, Lisi L, Catino S, Lanzone A, Apa R. Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells. Fertility and Sterility. 102: 831-7. PMID 25016925 DOI: 10.1016/j.fertnstert.2014.05.041  1
2014 Lisi L, Stigliano E, Lauriola L, Navarra P, Dello Russo C. Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells. Asn Neuro. 6: 171-83. PMID 24689533 DOI: 10.1042/AN20130045  1
2014 Greco MC, Lisi L, Currò D, Navarra P, Tringali G. Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro. Peptides. 56: 8-13. PMID 24662320 DOI: 10.1016/j.peptides.2014.03.009  1
2014 Dello Russo C, Lisi L, Fabbiani M, Gagliardi D, Fanti I, Di Giambenedetto S, Cauda R, Navarra P. Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data. Pharmacogenomics. 15: 319-27. PMID 24533711 DOI: 10.2217/pgs.13.242  1
2014 Lisi L, Tramutola A, Navarra P, Dello Russo C. Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism. Journal of Neuroimmunology. 266: 24-32. PMID 24268674 DOI: 10.1016/j.jneuroim.2013.10.013  1
2013 Fortuna S, Fabbiani M, Digiambenedetto S, Ragazzoni E, Lisi L, Cauda R, Navarra P. Variability of raltegravir plasma levels in the clinical setting. Pharmacology. 92: 43-8. PMID 23887354 DOI: 10.1159/000351851  1
2013 Romani F, Tropea A, Scarinci E, Dello Russo C, Lisi L, Catino S, Lanzone A, Apa R. Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews. 31: 170-80. PMID 23672405 DOI: 10.1080/10590501.2013.782180  1
2013 Ciucci A, De Stefano I, Vellone VG, Lisi L, Bottoni C, Scambia G, Zannoni GF, Gallo D. Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival. Plos One. 8: e60145. PMID 23555905 DOI: 10.1371/journal.pone.0060145  1
2013 Fortuna S, Ragazzoni E, Lisi L, Di Giambenedetto S, Fabbiani M, Navarra P. Validation of an UPLC-MS/MS method for quantitative analysis of raltegravir in human plasma samples. Therapeutic Drug Monitoring. 35: 258-63. PMID 23407478 DOI: 10.1097/FTD.0b013e318280110d  1
2013 Lisi L, Camardese G, Treglia M, Tringali G, Carrozza C, Janiri L, Dello Russo C, Navarra P. Monocytes from depressed patients display an altered pattern of response to endotoxin challenge. Plos One. 8: e52585. PMID 23300980 DOI: 10.1371/journal.pone.0052585  1
2013 Lisi L, McGuire S, Sharp A, Chiosis G, Navarra P, Feinstein DL, Dello Russo C. The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE. Journal of Neuroimmunology. 255: 1-7. PMID 23123171 DOI: 10.1016/j.jneuroim.2012.10.008  1
2013 Dello Russo C, Lisi L, Feinstein DL, Navarra P. mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis. Glia. 61: 301-11. PMID 23044764 DOI: 10.1002/glia.22433  1
2012 Tringali G, Greco MC, Lisi L, Pozzoli G, Navarra P. Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. Peptides. 34: 353-9. PMID 22342595 DOI: 10.1016/j.peptides.2012.02.004  1
2012 Lisi L, Navarra P, Cirocchi R, Sharp A, Stigliano E, Feinstein DL, Dello Russo C. Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 243: 43-51. PMID 22264993 DOI: 10.1016/j.jneuroim.2011.12.018  1
2012 Lisi L, Tramutola A, De Luca A, Navarra P, Dello Russo C. Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120. Journal of Neurochemistry. 120: 106-14. PMID 22017448 DOI: 10.1111/j.1471-4159.2011.07549.x  1
2011 De Corato A, Lisi L, Capuano A, Tringali G, Tramutola A, Navarra P, Dello Russo C. Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. Journal of Neuroimmunology. 237: 39-46. PMID 21719118 DOI: 10.1016/j.jneuroim.2011.05.013  1
2011 Dello Russo C, Lisi L, Lofaro A, Di Giambenedetto S, Federico B, Madeddu G, Salerno M, Mura MS, Pirazzoli A, de Luca A, Cauda R, Navarra P. Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR. Pharmacogenomics. 12: 567-76. PMID 21521028 DOI: 10.2217/pgs.10.208  1
2011 Lin SX, Lisi L, Dello Russo C, Polak PE, Sharp A, Weinberg G, Kalinin S, Feinstein DL. The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1. Asn Neuro. 3. PMID 21382015 DOI: 10.1042/AN20100033  1
2011 Lisi L, Navarra P, Feinstein DL, Dello Russo C. The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes. Journal of Neuroinflammation. 8: 1. PMID 21208419 DOI: 10.1186/1742-2094-8-1  1
2009 Capuano A, De Corato A, Lisi L, Tringali G, Navarra P, Dello Russo C. Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Molecular Pain. 5: 43. PMID 19660121 DOI: 10.1186/1744-8069-5-43  1
2009 Dello Russo C, Lisi L, Tringali G, Navarra P. Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation. Biochemical Pharmacology. 78: 1242-51. PMID 19576187 DOI: 10.1016/j.bcp.2009.06.097  1
2009 Dello Russo C, Lisi L, Navarra P, Tringali G. Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes. Journal of Neuroimmunology. 213: 78-83. PMID 19552966 DOI: 10.1016/j.jneuroim.2009.05.016  1
2009 Tringali G, Lisi L, De Simone ML, Aubry JM, Preziosi P, Pozzoli G, Navarra P. Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 1017-21. PMID 19467289 DOI: 10.1016/j.pnpbp.2009.05.012  1
2008 Tringali G, Lisi L, Bettella F, Renier D, Di Stasi SM, Navarra P. The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 58: 340-3. PMID 18848989 DOI: 10.1016/j.phrs.2008.09.008  1
2007 Tringali G, Pozzoli G, Lisi L, Navarra P. Erythropoietin inhibits basal and stimulated corticotropin-releasing hormone release from the rat hypothalamus via a nontranscriptional mechanism. Endocrinology. 148: 4711-5. PMID 17615151 DOI: 10.1210/en.2007-0431  1
Show low-probability matches.